Free Trial
→ Why major institutions are piling into this digital asset now (From Awesomely) (Ad)tc pixel
OTCMKTS:HYPMY

Hypermarcas Q3 2025 Earnings Results & Report

Hypermarcas logo
$5.30 0.00 (0.00%)
As of 10/9/2026 09:45 AM Eastern

Hypermarcas reported Q3 2025 earnings on November 12, 2025. The company reported EPS of $0.13, while revenue was $408.83 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q3 2025
Report Date
Time
Before Market Opens

Hypermarcas EPS Results

Actual EPS
$0.13
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Hypermarcas Revenue Results

Actual Revenue
$408.83 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Hypermarcas' next earnings date is estimated for Wednesday, November 11, 2026, based on past reporting schedules.

Conference Call Resources

Hypermarcas Q3 2025 Earnings FAQ

Hypermarcas (OTCMKTS:HYPMY) reported earnings of $0.13 per share for Q3 2025. The report was announced on Wednesday, November 12, 2025.

Hypermarcas reported revenue of $408.83 million for Q3 2025.

Hypermarcas' next earnings date is estimated for Wednesday, November 11, 2026. MarketBeat tracks confirmed and estimated earnings dates for Hypermarcas on the company's earnings history page.

Hypermarcas Earnings Headlines

Hypermarcas (OTCMKTS:HYPMY) Sees Unusually-High Trading Volume - Should You Buy?
October 6, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31092953
Hypermarcas (OTCMKTS:HYPMY) Reaches New 12-Month High - Should You Buy?
October 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31087455
Free Ticker: Anthropic's silent partner could soar after record $2 trillion IPO
Anthropic's IPO prospectus just leaked, revealing 261 pages tied to a record $2 trillion valuation. Beyond headline backers Amazon and Google, tech analyst Matt McCall has tracked a smaller partner that got in early, before most investors knew Claude existed. Matt calls it a Second IPO opportunity and reveals its name and ticker in a free interview.tc pixel
October 12 at 1:00 AM  |  Monument Traders Alliance (Ad)
Head to Head Comparison: NRx Pharmaceuticals (NASDAQ:NRXP) & Hypermarcas (OTCMKTS:HYPMY)
October 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31086043
Hypera ON ADR (HYPMY)
September 27, 2026  |  es.investing.comhttps://es.investing.com/equities/hypermarcas-sa-news
Hypera S.A. (HYPMY) Q2 2026 Earnings Call Transcript
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934927-hypera-s-a-hypmy-q2-2026-earnings-call-transcript
See More Hypermarcas Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hypermarcas? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hypermarcas and other key companies, straight to your email.

About Hypermarcas

Hypermarcas (OTCMKTS:HYPMY) S.A. was a Brazilian consumer healthcare company that developed, manufactured and marketed pharmaceutical and healthcare products. Its portfolio included over-the-counter medicines, prescription products, vitamins and other consumer health brands sold through pharmacies and retail channels.

The company was historically associated with well-known Brazilian brands such as Benegrip, Biotônico Fontoura, Doril, Engov and Epocler. Hypermarcas also previously operated in personal care, beauty, household cleaning and other consumer categories, but divested many of those businesses as it concentrated on pharmaceuticals and healthcare.

In 2018, Hypermarcas changed its corporate name to Hypera S.A., adopting the Hypera Pharma identity. The company’s principal market has been Brazil, with its operations focused on serving the Brazilian healthcare and pharmaceutical market.

View Hypermarcas Profile
Earnings Tools